Trade Summary

6 days ago, Doraiswamy Vinayak, serving as Chief Scientific Officer at Atricure, Inc. (ATRC), sold 5,000 shares at $29.83 per share, for a total transaction value of $149,150.00. Following this transaction, Doraiswamy Vinayak now holds 96,875 shares of ATRC.

This sale represents a 5.00% decrease in Doraiswamy Vinayak's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, March 12, 2026 and publicly disclosed via SEC Form 4 filing on Monday, March 16, 2026, 4 days after the trade was made.

Atricure, Inc. operates in the HEALTHCARE sector, specifically within the MEDICAL INSTRUMENTS & SUPPLIES industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.